MyAV范

The aim of the聽platform聽is to speed up scientific advances and ultimately bring health benefits to people sooner. Neucruit recently secured a 拢300,000 grant from Innovate UK to aid with COVID-19 clinical research.

MyAV范-born startup

Neucruit grew out of the MyAV范 Artificial Intelligence (AI) Society, led by founder Livia Ng (MyAV范 BSc Neuroscience).

Formerly called CT-X, the startup moved into BaseKX, MyAV范鈥檚 dedicated entrepreneurship hub in early 2020. There they received business advice, mentorship and the right environment to structure and grow the company further.

Streamlining clinical trials

Neucruit鈥檚 solution consists of a web-based trial management system that uses AI to automate patient recruitment and retention into clinical trials.聽

The platform uses natural language processing (NLP) and outreach algorithms to automate the patient outreach process, analyse patient profiles and help diversify/optimise patient samples. This automation means researchers can meet recruitment targets for trials faster and cheaper than by using existing methods.

For prospective participants, the platform helps them understand what鈥檚 involved in clinical research and ensures they give informed consent. It also makes sure they remain part of the study for its duration, helping ensuring success of the clinical trial.

Supporting COVID-19 research

Neucruit has already been working with 12 universities globally, on 56 research studies involving 2,500 patients. Many of these studies are community-based, mental health studies. But the recent Innovative UK funding presents an unparalleled new opportunity, as Livia Ng, now CEO of Neucruit, explains:聽

鈥淥ver the next year, we鈥檙e going to be using the funding to build our platform to facilitate COVID-19 clinical research in the UK. There are going to be three trials, all COVID-19 related, looking at preventative measures and outcomes with respect to health comorbidities or social factors in a clinical setting.鈥�

Livia adds that Neucruit retains strong links with MyAV范 Innovation & Enterprise and collaborates with various MyAV范 academic departments on research trials.

Jerry Allen, Director of Entrepreneurship at MyAV范 Innovation & Enterprise, said: 鈥淲ith the coronavirus pandemic likely to be with us in some form for years, solutions like Neucruit will help us adapt. Their platform will expedite research into COVID-19 and other areas of health and wellbeing.

鈥淭he company has benefited enormously from the entire MyAV范 ecosystem. From the vibrant student AI society, to the advice and mentorship provided here at MyAV范 Innovation & Enterprise and links with clinical and academic departments. I wish them all the best in their mission.鈥�

Links

Find out more about:

• entrepreneurship support for MyAV范 students
• MyAV范 BSc Neuroscience
• MyAV范 startup wins award for software designed to improve clinical trial recruitment

Photo聽漏聽Kirsten Holst